health insurance

Kookmin Bank, a unit of KB Financial Group, raised $700 million in foreign exchange bonds on Tuesday, signaling a recovery in investor sentiment tow...

CJ CheilJedang Corp., South Korea’s largest food company, has cancelled the sale of a 66% stake in Brazilian soybean crusher CJ Selecta S.A. a...

Kyobo Life Insurance Co. is in the final stages of negotiation with Japanese financial group SBI Holdings Inc. to buy about a 50% stake in SBI Savin...

In an ambitious bid to shape the future of technology, Samsung Electronics Co. is launching a sweeping initiative to collaborate with elite North Am...

DB Insurance Co., a leading South Korean non-life insurance company, has become Daol Investment & Securities Co.'s second-largest shareholder af...

South Korean consumers exhibited recessionary spending behavior in March, cutting expenditures across nearly all sectors, except healthcare and educ...

South Korean consumers exhibited recessionary spending behavior in March, cutting expenditures across nearly all sectors, except healthcare and educ...

Kakao Corp. founder Kim Beom-soo, also known as Brian Kim, will step down as chairman of the South Korean tech giant’s top decision-making bod...

Meritz Financial Group Inc., South Korea’s second-most valuable financial holding firm, has dropped its bid to acquire financial distressed MG...

Samsung Group companies will jointly invest $10 million in C2N Diagnostics LLC, a U.S.-based company specializing in blood-based Alzheimer’s d...

Affinity Equity Partners and Singapore’s sovereign wealth fund GIC have sold their entire stake in Kyobo Life Insurance Co., exiting from thei...

Seoul Guarantee Insurance Co. (SGI) will raise 181.5 billion won ($124.2 million) through an initial public offering later this month in its second ...

South Korean companies are relaunching attempts to go public with lower valuations and fewer shares amid continued sour investor sentiment.CK Soluti...

Seoul Guarantee Insurance Co. (SGI) has slashed its target valuation by about 40% in a renewed attempt to go public on the South Korean stock exchan...

South Korea’s Celltrion Inc., received new drug submission (NDS) approval from Health Canada for Omlyclo, the biosimilar of allergic asthma an...

South Korea's Hanwha Life Insurance said on Wednesday it signed a stock purchase agreement (SPA) to acquire a 75% stake in Velocity Clearing LLC, ...

South Korea's biotech company Macrogen, Inc. signed a supply agreement to integrate its genome analysis platform, GenTok, into the Samsung Health ap...

South Korea's SK C&C said on Thursday that it launched its Digital SHE Consulting Service,  the artificial intelligence (AI) platform tha...

Lunit, a South Korean cancer diagnostics AI company, said on Monday its US subsidiary Volpara Health secured a 10 billion won ($7.5 million) contr...

South Korean biosimilar maker Celltrion Inc. said on Monday its subcutaneous injection formulation for autoimmune diseases, Zymfentra (infliximab), ...

LG CNS Co., DN Solutions Co. and other South Korean companies aim to raise billions of dollars through domestic initial public offerings (IPOs) in J...

South Korea's major pension and savings funds see no drastic reshuffle to their portfolios tilted to private debts next year. But they are looking t...

DB Insurance Co. raked in the biggest profits from overseas operations among South Korean insurance companies in the first half of this year, leadin...

Samsung Electronics Co. on Thursday introduced the Samsung Health Software Development Kit (SDK) Suite, aimed at helping developers and researchers ...

South Korea's Hanwha Galleria Corp. said on Monday its acquisition of domestic beverage manufacturer Pure Plus.Pure Plus has focused on non-alcoholi...

South Korea's Lotte Home Shopping signed an exclusive agreement with Japan's Asahi Group Foods to supply and sell health functional food ingredients...

Lunit, a South Korean cancer diagnostics AI company, announced on Wednesday that its subsidiary Volpara Health, a New Zealand-based AI software deve...

SK Group, the second-largest conglomerate in South Korea, is considering selling global leading specialty gas producer SK Specialty Co. for around 4...

South Korean biosimilar maker Celltrion Inc. said on Monday that its subcutaneous injection formulation for autoimmune diseases, Zymfentra (inflixim...

South Korea’s Celltrion Inc., received new drug submission (NDS) approval from Health Canada for Steqeyma, a biosimilar of the autoimmune dise...